Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Physiology and Pharmacology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15082879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Helicobacter pylori stimulates host cyclooxygenase‐2 gene transcription: critical importance of MEK/ERK‐dependent activation of USF1/‐2 and CREB transcription factors

  2003cited by this paper
• A prospective randomized safety trial of celecoxib for treatment of preterm labor.

  2002cited by this paper
• Effects of Cyclooxygenase-2 Inhibitor on Gastric Acid Secretion in Helicobacter pylori -infected C57BL/6 Mice

  2001cited by this paper
• Expression of Cyclooxygenase-2 in Human Neutrophils Activated by Helicobacter pylori Water-Soluble Proteins: Possible Involvement of NF-κB and MAP Kinase Signaling Pathway

  2001cited by this paper
• Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice.

  2001cited by this paper
• Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway.

  2001cited by this paper
• Prostaglandin E Inhibits Indomethacin-Induced Gastric Lesions through EP-1 Receptors

  2001cited by this paper
• Gastric mucosal changes induced by long term infection with Helicobacter pylori in Mongolian gerbils: effects of bacteria eradication.

  2001cited by this paper
• Mechanism for Helicobacter pylori stimulation of interleukin-8 production in a gastric epithelial cell line (MKN 28): roles of mitogen-activated protein kinase and interleukin-1beta.

  2001cited by this paper
• Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.

  2001cited by this paper
• EFFECTS OF INDOMETHACIN ON THE DEVELOPMENT OF ULCERS IN HELICOBACTER PYLORI-INFECTED MONGOLIAN GERBILS

  2001cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

  2000cited by this paper
• The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000cited by this paper
• Activated Neutrophils Impair Gastric Cytoprotection: Role of Neutrophil Elastase

  2000cited by this paper
• Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

  1999cited by this paper
• Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

  1999cited by this paper
• Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.

  1999cited by this paper
• EP4 receptor mediation of prostaglandin E2-stimulated mucus secretion by rabbit gastric epithelial cells.

  1999cited by this paper
• Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

  1998cited by this paper
• Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage.

  1998cited by this paper
• Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

  1997cited by this paper
• Helicobacter pylori inhibits the secretory activity of gastric parietal cells in patients with chronic gastritis. An ultrastructural study.

  1997cited by this paper
• Infiltration of neutrophils by intrapleural injection of tumour necrosis factor, interleukin‐1, and interleukin‐8 in rats, and its modification by actinomycin D

  1996cited by this paper
• Inhibition of vagally mediated gastric acid secretion by activation of central prostanoid EP3 receptors in urethane‐anaesthetized rats

  1996cited by this paper
• Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat.

  1994cited by this paper
• Age-related reductions in gastric mucosal prostaglandin levels increase susceptibility to aspirin-induced injury in rats.

  1994cited by this paper
• Effects of Helicobacter pylori on histamine and carbachol stimulated acid secretion by human parietal cells.

  1994cited by this paper
• Nonessential role of leukotrienes as mediators of acute gastric mucosal injury induced by aspirin in rats

  1992cited by this paper
• Oxygen Free Radicals and Lipid Peroxidation in the Pathogenesis of Gastric Mucosal Lesions Induced by Indomethacin in Rats

  1991cited by this paper
• Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Relation to gastric hypermotility.

  1991cited by this paper
• Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

  1991cited by this paper
• Bilateral adrenalectomy worsens gastric mucosal lesions induced by indomethacin in the rat. Role of enhanced gastric motility.

  1989cited by this paper
• Role of prostaglandins in regulating gastric motility.

  1984cited by this paper
• Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: Assessment of inflammation in rat and hamster models

  1984cited by this paper
• Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

  1984cited by this paper
• Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases.

  1980cited by this paper
• Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases

  1980cited by this paper

• Omeprazole and H2S releasing agents encapsulated in chitosan nanoparticles to enhance healing process against indomethacin-induced gastric ulcer model

  2023cites this paper
• Novel CD-MOF NIR-II fluorophores for gastric ulcer imaging

  2021cites this paper
• Investigating anti-neuroinflammatory mechanism of orientin in lipopolysaccharide-induced BV2 microglia cells

  2019cites this paper
• Suppression of Expression of Endoplasmic Reticulum Chaperones by Helicobacter pylori and Its Role in Exacerbation of Non-steroidal Anti-inflammatory Drug-induced Gastric Lesions*

  2010cites this paper
• Involvement of cyclooxygenase 2 and prostagladin E(2) in the effects of insulin on gastric emptying in male rats.

  2009cites this paper
• Gastroprotective effect of leptin in indomethacin-induced gastric injury.

  2008cites this paper
• Effects of Cyclooxygenase-1 and -2 Inhibition on Gastric Acid Secretion and Cardiovascular Functions in Rats

  2006cites this paper
• Helicobacter pylori inhibits expression of heat shock protein 70 (HSP70) in human epithelial cell line. Importance of Cag A protein.

  2006cites this paper
• UNIVERSIDADE FEDERAL DO CEARÁ FACULDADE DE MEDICINA CURSO DE PÓS-GRADUAÇÃO EM FARMACOLOGIA ESTUDO DAS PROPRIEDADES FARMACOLÓGICAS DA RESINA DE Protium heptaphyllum (Aubl.) March. E DE SEUS PRINCIPAIS CONSTITUINTES, MISTURA DE α- E β-AMIRINA

  2005cites this paper
• Herbal Complement Inhibitors in the Treatment of Neuroinflammation: Future Strategy for Neuroprotection

  2005cites this paper